首页 > 最新文献

Rare Tumors最新文献

英文 中文
Ovarian serous borderline tumor with mural nodules of anaplastic carcinoma and omental involvement: A case report. 卵巢浆液性交界性肿瘤伴间变性癌壁结节及网膜受累1例。
IF 0.9 Q4 Medicine Pub Date : 2023-01-01 DOI: 10.1177/20363613231172260
Paula I Hernandez Acevedo, Gloria J Carter, Madeleine Courtney-Brooks, Beth Z Clark

Mural nodules are rarely identified in cystic ovarian neoplasms, and have been categorized into sarcoma-like, sarcomatous, and anaplastic carcinomatous types. Most reports of these mural nodules have been described in mucinous ovarian tumors. In this case report, we describe an ovarian serous borderline tumor with mural nodules composed of high-grade carcinoma with anaplastic features and necrosis, including the morphologic features, immunoprofile, and results of tumor DNA sequencing. Omental involvement was also identified. Recognition of this phenomenon in serous tumors is important, so that thickened areas of cyst wall in ovarian serous tumors will be thoroughly examined.

壁结节在卵巢囊性肿瘤中很少发现,可分为肉瘤样、肉瘤性和间变性癌。大多数关于这些壁结节的报道都是在卵巢粘液性肿瘤中描述的。在这个病例报告中,我们描述了一个卵巢浆液性交界性肿瘤,伴有壁结节,由高级别癌组成,具有间变性特征和坏死,包括形态学特征、免疫谱和肿瘤DNA测序结果。还发现了网膜受累。认识浆液性肿瘤的这种现象是很重要的,因此卵巢浆液性肿瘤的囊肿壁增厚区域将被彻底检查。
{"title":"Ovarian serous borderline tumor with mural nodules of anaplastic carcinoma and omental involvement: A case report.","authors":"Paula I Hernandez Acevedo,&nbsp;Gloria J Carter,&nbsp;Madeleine Courtney-Brooks,&nbsp;Beth Z Clark","doi":"10.1177/20363613231172260","DOIUrl":"https://doi.org/10.1177/20363613231172260","url":null,"abstract":"<p><p>Mural nodules are rarely identified in cystic ovarian neoplasms, and have been categorized into sarcoma-like, sarcomatous, and anaplastic carcinomatous types. Most reports of these mural nodules have been described in mucinous ovarian tumors. In this case report, we describe an ovarian serous borderline tumor with mural nodules composed of high-grade carcinoma with anaplastic features and necrosis, including the morphologic features, immunoprofile, and results of tumor DNA sequencing. Omental involvement was also identified. Recognition of this phenomenon in serous tumors is important, so that thickened areas of cyst wall in ovarian serous tumors will be thoroughly examined.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"15 ","pages":"20363613231172260"},"PeriodicalIF":0.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/53/db/10.1177_20363613231172260.PMC10126381.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9364653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fibrous dysplasia associated with peripheral giant cell granoluma in maxilla in a young patient, a case report of rare hybrid lesion. 年轻患者上颌骨纤维发育不良伴外周巨细胞肉芽肿1例,为罕见的混合型病变。
IF 0.9 Q4 Medicine Pub Date : 2023-01-01 DOI: 10.1177/20363613231165883
Abbas Karimi, Samira Derakhshan, Mahboube Hasheminasab, Sheida Kordi

Benign fibro-osseous lesions are a diverse range of entities that have distinct clinical and radiographic features. They can occur as solitary lesions or concomitant with other pathologies as hybrid lesions. Fibrous dysplasia (FD) accompanied by central giant cell granuloma (CGCG), peripheral giant cell granuloma (PGCG) or peripheral ossifying fibroma (POF) as hybrid lesions, is reported very rarely in the literature. Although we were unable to find any reports of FD with PGCG as a hybrid lesion. Fibro-osseous lesions have certain histopathological features in common with PGCG including multinucleated giant cells. Here we report a 28 year old female with a painless, slow growing and pedunculated swelling of the maxilla for 18 months. Differential diagnosis consisted of FD, cemento-ossifying fibroma (COF), chondrosarcoma and probable PGCG considering radiographic and clinical investigations. Histopathologic findings revealed PGCG and FD as a hybrid lesion. The combination of PGCG and FD has not been reported in the literature so far.

良性纤维骨性病变是多种多样的实体,具有不同的临床和影像学特征。它们可以作为单独的病变发生,也可以作为混合病变与其他病理同时发生。纤维结构不良(FD)合并中央巨细胞肉芽肿(CGCG)、外周巨细胞肉芽肿(PGCG)或外周骨化纤维瘤(POF)为混合型病变,文献报道甚少。虽然我们没有发现任何FD与PGCG作为混合性病变的报道。纤维骨性病变与PGCG有一定的组织病理学特征,包括多核巨细胞。我们在此报告一位28岁的女性患者,她的上颌骨出现无痛、生长缓慢和带蒂的肿胀,持续了18个月。鉴别诊断包括FD,骨质骨化纤维瘤(COF),软骨肉瘤和可能的PGCG结合影像学和临床检查。组织病理学结果显示PGCG和FD为混合型病变。迄今为止,PGCG与FD合用尚未见文献报道。
{"title":"Fibrous dysplasia associated with peripheral giant cell granoluma in maxilla in a young patient, a case report of rare hybrid lesion.","authors":"Abbas Karimi,&nbsp;Samira Derakhshan,&nbsp;Mahboube Hasheminasab,&nbsp;Sheida Kordi","doi":"10.1177/20363613231165883","DOIUrl":"https://doi.org/10.1177/20363613231165883","url":null,"abstract":"<p><p>Benign fibro-osseous lesions are a diverse range of entities that have distinct clinical and radiographic features. They can occur as solitary lesions or concomitant with other pathologies as hybrid lesions. Fibrous dysplasia (FD) accompanied by central giant cell granuloma (CGCG), peripheral giant cell granuloma (PGCG) or peripheral ossifying fibroma (POF) as hybrid lesions, is reported very rarely in the literature. Although we were unable to find any reports of FD with PGCG as a hybrid lesion. Fibro-osseous lesions have certain histopathological features in common with PGCG including multinucleated giant cells. Here we report a 28 year old female with a painless, slow growing and pedunculated swelling of the maxilla for 18 months. Differential diagnosis consisted of FD, cemento-ossifying fibroma (COF), chondrosarcoma and probable PGCG considering radiographic and clinical investigations. Histopathologic findings revealed PGCG and FD as a hybrid lesion. The combination of PGCG and FD has not been reported in the literature so far.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"15 ","pages":"20363613231165883"},"PeriodicalIF":0.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2e/c9/10.1177_20363613231165883.PMC10134184.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9450500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Solitary amyloid tumor of the palate: A case report and literature review. 上颚单发淀粉样瘤1例报告并文献复习。
IF 0.9 Q4 Medicine Pub Date : 2023-01-01 DOI: 10.1177/20363613231166540
Farnoosh Razmara, Samira Derakhshan, Nazanin Mahdavi, Saba Mohammadi

Amyloidosis is often caused by the abnormal extracellular accumulation of amyloid in organs and tissues. This condition, affecting the head and neck region, is typically localized, and may also involve the oral cavity, particularly the tongue and buccal mucosa. As a solitary manifestation, the localized amyloidosis occurring intraosseous is highly infrequent. In addition, localized amyloidosis has a great rate of recurrence. In this paper, a 50-year-old female patient with the chief complaint of pain in the anterior of the maxilla is reported. According to clinical examination, no significant pathologic lesion was seen. The radiographic image showed a radiolucent lesion around teeth four and five. The treatment of choice for the patient was an excisional biopsy. As amyloidosis diagnosis is clinically challenging, biopsy and histologic examination of lesions are necessary in this regard. Accordingly, it is concluded that long-term follow-up is mandatory in case of localized amyloidosis because late recurrence can occur in some cases.

淀粉样变性通常是由器官和组织中淀粉样蛋白的细胞外异常积聚引起的。这种情况影响头颈部,通常是局部的,也可能累及口腔,特别是舌头和颊粘膜。作为一种孤立的表现,局部淀粉样变发生在骨内是非常罕见的。此外,局限性淀粉样变性有很高的复发率。本文报告一位50岁女性患者,主诉为上颌骨前部疼痛。临床检查未见明显病理病变。x线片显示在第四和第五颗牙齿周围有一个透光的病变。患者的治疗选择是切除活检。由于淀粉样变的诊断在临床上具有挑战性,因此对病变进行活检和组织学检查是必要的。因此,我们得出结论,对于局限性淀粉样变性患者,长期随访是必要的,因为某些病例可能出现晚期复发。
{"title":"Solitary amyloid tumor of the palate: A case report and literature review.","authors":"Farnoosh Razmara,&nbsp;Samira Derakhshan,&nbsp;Nazanin Mahdavi,&nbsp;Saba Mohammadi","doi":"10.1177/20363613231166540","DOIUrl":"https://doi.org/10.1177/20363613231166540","url":null,"abstract":"<p><p>Amyloidosis is often caused by the abnormal extracellular accumulation of amyloid in organs and tissues. This condition, affecting the head and neck region, is typically localized, and may also involve the oral cavity, particularly the tongue and buccal mucosa. As a solitary manifestation, the localized amyloidosis occurring intraosseous is highly infrequent. In addition, localized amyloidosis has a great rate of recurrence. In this paper, a 50-year-old female patient with the chief complaint of pain in the anterior of the maxilla is reported. According to clinical examination, no significant pathologic lesion was seen. The radiographic image showed a radiolucent lesion around teeth four and five. The treatment of choice for the patient was an excisional biopsy. As amyloidosis diagnosis is clinically challenging, biopsy and histologic examination of lesions are necessary in this regard. Accordingly, it is concluded that long-term follow-up is mandatory in case of localized amyloidosis because late recurrence can occur in some cases.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"15 ","pages":"20363613231166540"},"PeriodicalIF":0.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e6/d9/10.1177_20363613231166540.PMC10037730.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9183380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DCvax: A promising advancement in oncology for the treatment of glioblastoma. DCvax:肿瘤治疗胶质母细胞瘤的一个有希望的进展。
IF 0.9 Q4 ONCOLOGY Pub Date : 2023-01-01 DOI: 10.1177/20363613231179541
Areeba Fareed, Samia Rohail, Alishba Adnan, Abdul Moiz Khan
Dear Editor, Glioblastoma is a malignant neoplasm of the central nervous system that arises from glial cells, primarily astrocyctes and is characterized by poorly differentiated, fusiform, round or pleomorphic astrocyctic cells with marked nuclear atypical and brisk mitotic activity. Despite advances in early diagnosis and comprehensive treatments, there is nearly 100% recurrence rate and dismal patient survival. According to researchers, more than 13,000 Americans are diagnosed with Glioblastoma annually, causing significant morbidity and mortality. There has been no cure for Glioblastoma so far. Treatment options often include surgical removal of the tumor followed by concomitant radiation and adjuvant temozolomide TMZ chemotherapy which has been the standard of care for glioblastoma since decades, but exposure to high doses of ionizing radiation is a well-known exogenous risk factor for glioblastoma. The inability to cross the BBB is the major obstacle in achieving remission after surgical resection followed by chemotherapy and radiation. As a result, glioblastoma typically recurs within six to 8 months and the survival rate is generally less than 5%. Despite the development of novel, complex, multidisciplinary, and targeted therapies the outcome for patients remains almost universally lethal. Therefore, the need for effective treatment is undeniable. For this reason, it has been a priority area in cancer research. Recently, US biotech company Northwest Biotherapeutics has developed a brain cancer vaccine, called DCVax, which is designed to help patients’ immune system to target their tumors that may prolong their life by months or, in some cases, years. Thus, opening a door for the development of innovative therapy for targeting glioblastoma. The vaccine is created for each patient individually by isolating dendritic cells, from their blood which is then primed with biomarkers from a sample of the patient’s tumor. Dendritic cells present tumor antigens to the immune system, prime T cells, and mobilize antitumor responses. To evaluate the safety of the vaccine and its impact on survival time in patients with Glioblastoma, a phase 3 randomized control trial was conducted. In this trial, 348 patients newly diagnosed with Glioblastoma were tested at King’s College Hospital and other centers around the world for 8 years. Patients had surgery to remove their tumors as much as possible, followed by radiation and chemotherapy as the standard treatment for Glioblastoma. Among these patients, two out of three were treated with the vaccine, DCVax-L, with the remaining one-third receiving a placebo. The astonishing result of the trial has shown that newly diagnosed patients who received the vaccine survived for 19.3 months compared to 16.5 months for those who received a placebo. Overall 13% of all trial participants treated with DCVax lived more than 5 years after diagnosis compared with 5.7% in the comparison group
{"title":"DCvax: A promising advancement in oncology for the treatment of glioblastoma.","authors":"Areeba Fareed,&nbsp;Samia Rohail,&nbsp;Alishba Adnan,&nbsp;Abdul Moiz Khan","doi":"10.1177/20363613231179541","DOIUrl":"https://doi.org/10.1177/20363613231179541","url":null,"abstract":"Dear Editor, Glioblastoma is a malignant neoplasm of the central nervous system that arises from glial cells, primarily astrocyctes and is characterized by poorly differentiated, fusiform, round or pleomorphic astrocyctic cells with marked nuclear atypical and brisk mitotic activity. Despite advances in early diagnosis and comprehensive treatments, there is nearly 100% recurrence rate and dismal patient survival. According to researchers, more than 13,000 Americans are diagnosed with Glioblastoma annually, causing significant morbidity and mortality. There has been no cure for Glioblastoma so far. Treatment options often include surgical removal of the tumor followed by concomitant radiation and adjuvant temozolomide TMZ chemotherapy which has been the standard of care for glioblastoma since decades, but exposure to high doses of ionizing radiation is a well-known exogenous risk factor for glioblastoma. The inability to cross the BBB is the major obstacle in achieving remission after surgical resection followed by chemotherapy and radiation. As a result, glioblastoma typically recurs within six to 8 months and the survival rate is generally less than 5%. Despite the development of novel, complex, multidisciplinary, and targeted therapies the outcome for patients remains almost universally lethal. Therefore, the need for effective treatment is undeniable. For this reason, it has been a priority area in cancer research. Recently, US biotech company Northwest Biotherapeutics has developed a brain cancer vaccine, called DCVax, which is designed to help patients’ immune system to target their tumors that may prolong their life by months or, in some cases, years. Thus, opening a door for the development of innovative therapy for targeting glioblastoma. The vaccine is created for each patient individually by isolating dendritic cells, from their blood which is then primed with biomarkers from a sample of the patient’s tumor. Dendritic cells present tumor antigens to the immune system, prime T cells, and mobilize antitumor responses. To evaluate the safety of the vaccine and its impact on survival time in patients with Glioblastoma, a phase 3 randomized control trial was conducted. In this trial, 348 patients newly diagnosed with Glioblastoma were tested at King’s College Hospital and other centers around the world for 8 years. Patients had surgery to remove their tumors as much as possible, followed by radiation and chemotherapy as the standard treatment for Glioblastoma. Among these patients, two out of three were treated with the vaccine, DCVax-L, with the remaining one-third receiving a placebo. The astonishing result of the trial has shown that newly diagnosed patients who received the vaccine survived for 19.3 months compared to 16.5 months for those who received a placebo. Overall 13% of all trial participants treated with DCVax lived more than 5 years after diagnosis compared with 5.7% in the comparison group","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"15 ","pages":"20363613231179541"},"PeriodicalIF":0.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0f/7f/10.1177_20363613231179541.PMC10225952.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10298410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Granular cell tumor of the lung and tracheobronchial tree: Two case-presentation with a review of the literature. 肺及气管支气管树状颗粒细胞瘤:两例报告并文献复习。
IF 0.9 Q4 ONCOLOGY Pub Date : 2023-01-01 DOI: 10.1177/20363613231187822
Yoldez Houcine, Mouna Mlika, Chirine Moussa, Houda Rouis, Emna Brahem, Olfa Ismail, Sonia Maȃlej, Faouzi El Mezni

Pulmonary granular cells tumors (CGT) are rare tumors, that derive from Schwann cells. In the tracheobronchial and pulmonary tree, they remain a diagnostic challenge. There are no well-established criteria to differentiate between benign, atypical, and malignant GCT. Moreover, its real frequency in the respiratory tract is still unknown. Here, we represent 2 cases of bronchial and lung GCTs. We aim to highlight the frequency of all clinicopathological characteristics of this rare tumor in the tracheobronchial and pulmonary tree location based on our cases and the available literature in a large systematic review.

肺颗粒细胞瘤(CGT)是一种罕见的肿瘤,起源于雪旺细胞。在气管支气管和肺部,它们仍然是一个诊断挑战。没有明确的标准来区分良性、非典型和恶性GCT。此外,其在呼吸道的真实频率尚不清楚。在这里,我们报告了2例支气管和肺部的gct。我们的目的是根据我们的病例和现有的文献,在一个大型的系统回顾中强调所有临床病理特征在气管支气管和肺树位置的罕见肿瘤的频率。
{"title":"Granular cell tumor of the lung and tracheobronchial tree: Two case-presentation with a review of the literature.","authors":"Yoldez Houcine,&nbsp;Mouna Mlika,&nbsp;Chirine Moussa,&nbsp;Houda Rouis,&nbsp;Emna Brahem,&nbsp;Olfa Ismail,&nbsp;Sonia Maȃlej,&nbsp;Faouzi El Mezni","doi":"10.1177/20363613231187822","DOIUrl":"https://doi.org/10.1177/20363613231187822","url":null,"abstract":"<p><p>Pulmonary granular cells tumors (CGT) are rare tumors, that derive from Schwann cells. In the tracheobronchial and pulmonary tree, they remain a diagnostic challenge. There are no well-established criteria to differentiate between benign, atypical, and malignant GCT. Moreover, its real frequency in the respiratory tract is still unknown. Here, we represent 2 cases of bronchial and lung GCTs. We aim to highlight the frequency of all clinicopathological characteristics of this rare tumor in the tracheobronchial and pulmonary tree location based on our cases and the available literature in a large systematic review.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"15 ","pages":"20363613231187822"},"PeriodicalIF":0.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4c/ef/10.1177_20363613231187822.PMC10338731.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10302748","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pediatric diffuse hemispheric glioma H3 G34-mutant with gains of the BRAF locus: An illustrative case. 儿童弥漫性半球胶质瘤H3 g34突变体与BRAF基因座的增益:一个说明性病例。
IF 0.9 Q4 ONCOLOGY Pub Date : 2023-01-01 DOI: 10.1177/20363613231168704
Christine Marlow, Joshua A Cuoco, Austin R Hoggarth, Michael S Stump, Lisa S Apfel, Cara M Rogers

Diffuse hemispheric glioma, H3 G34-mutant, is a recently recognized distinct high-grade glioma with a dismal prognosis. In addition to the H3 G34 missense mutation, numerous genetic events have been identified in these malignant tumors, including ATRX, TP53, and, rarely, BRAF genes. There are only a few reports to date that have identified BRAF mutations in diffuse hemispheric glioma, H3 G34-mutant. Moreover, to our knowledge, gains of the BRAF locus have yet to be described. Here, we present a case of an 11-year-old male with a diffuse hemispheric glioma, H3 G34-mutant, found to have novel gains of the BRAF locus. Furthermore, we emphasize the current genetic landscape of diffuse hemispheric glioma, H3 G34-mutant, and implications of an aberrant BRAF signaling pathway.

弥漫性半球胶质瘤,H3 g34突变体,是最近发现的一种预后较差的高级别胶质瘤。除了h3g34错义突变外,在这些恶性肿瘤中还发现了许多遗传事件,包括ATRX、TP53和BRAF基因。迄今为止,只有少数报道在弥漫性半球胶质瘤中发现了BRAF突变,即H3 g34突变体。此外,据我们所知,BRAF基因座的增益尚未被描述。在这里,我们报告了一例11岁男性弥漫性半球胶质瘤,H3 g34突变体,发现BRAF位点有新的增益。此外,我们强调了弥漫性半球胶质瘤、H3 g34突变体和异常BRAF信号通路的当前遗传格局。
{"title":"Pediatric diffuse hemispheric glioma H3 G34-mutant with gains of the BRAF locus: An illustrative case.","authors":"Christine Marlow,&nbsp;Joshua A Cuoco,&nbsp;Austin R Hoggarth,&nbsp;Michael S Stump,&nbsp;Lisa S Apfel,&nbsp;Cara M Rogers","doi":"10.1177/20363613231168704","DOIUrl":"https://doi.org/10.1177/20363613231168704","url":null,"abstract":"<p><p>Diffuse hemispheric glioma, H3 G34-mutant, is a recently recognized distinct high-grade glioma with a dismal prognosis. In addition to the H3 G34 missense mutation, numerous genetic events have been identified in these malignant tumors, including <i>ATRX</i>, <i>TP53</i>, and, rarely, <i>BRAF</i> genes. There are only a few reports to date that have identified <i>BRAF</i> mutations in diffuse hemispheric glioma, H3 G34-mutant. Moreover, to our knowledge, gains of the <i>BRAF</i> locus have yet to be described. Here, we present a case of an 11-year-old male with a diffuse hemispheric glioma, H3 G34-mutant, found to have novel gains of the <i>BRAF</i> locus. Furthermore, we emphasize the current genetic landscape of diffuse hemispheric glioma, H3 G34-mutant, and implications of an aberrant BRAF signaling pathway.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"15 ","pages":"20363613231168704"},"PeriodicalIF":0.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d4/b1/10.1177_20363613231168704.PMC10088409.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9660217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Recurrent Aggressive Fibromatosis Coexisting With Papillary Carcinoma Thyroid - Case Report. 复发性侵袭性纤维瘤病合并甲状腺乳头状癌1例。
IF 0.9 Q4 ONCOLOGY Pub Date : 2023-01-01 DOI: 10.1177/20363613231172868
Bharath Bg, Sameer Rastogi, Ekta Dhamija, Adarsh Barwad

Background: Aggressive fibromatosis (AF) is a benign tumor that usually has a locally aggressive and recurrent disease course. Reports of association between AF and malignancies have been reported infrequently.

Case: We report a case of a 49-years lady who had papillary thyroid carcinoma associated with a distinct desmoid tumor occurring concurrently on the right side of the neck. Initial management comprised of total thyroidectomy followed by radio-iodine therapy and desmoid tumor resection. Recurrent AF developed at the same site as before after 2 years of resection. The recurrent tumor was managed with sorafenib, the patient responded with a resolution of symptoms, and the tumor remained stable. Beta-catenin mutation done by Sanger sequencing was negative in the tumor specimen.

Conclusion: AF can occur as a separate tumor in association with PTC. If symptoms are not life-threatening medical management may be a better choice in management.

背景:侵袭性纤维瘤病(AF)是一种良性肿瘤,通常具有局部侵袭性和复发性病程。心房颤动与恶性肿瘤之间的关联报道很少。病例:我们报告一位49岁的女性,她患有甲状腺乳头状癌,并同时发生在颈部右侧的明显的硬纤维瘤。最初的治疗包括甲状腺全切除术,放射碘治疗和硬纤维瘤切除术。术后2年,房颤复发部位与既往相同。复发肿瘤用索拉非尼治疗,患者症状缓解,肿瘤保持稳定。Sanger测序检测肿瘤标本β -连环蛋白突变阴性。结论:房颤可作为单独的肿瘤与PTC相关。如果症状不危及生命,医疗管理可能是更好的选择。
{"title":"Recurrent Aggressive Fibromatosis Coexisting With Papillary Carcinoma Thyroid - Case Report.","authors":"Bharath Bg,&nbsp;Sameer Rastogi,&nbsp;Ekta Dhamija,&nbsp;Adarsh Barwad","doi":"10.1177/20363613231172868","DOIUrl":"https://doi.org/10.1177/20363613231172868","url":null,"abstract":"<p><strong>Background: </strong>Aggressive fibromatosis (AF) is a benign tumor that usually has a locally aggressive and recurrent disease course. Reports of association between AF and malignancies have been reported infrequently.</p><p><strong>Case: </strong>We report a case of a 49-years lady who had papillary thyroid carcinoma associated with a distinct desmoid tumor occurring concurrently on the right side of the neck. Initial management comprised of total thyroidectomy followed by radio-iodine therapy and desmoid tumor resection. Recurrent AF developed at the same site as before after 2 years of resection. The recurrent tumor was managed with sorafenib, the patient responded with a resolution of symptoms, and the tumor remained stable. Beta-catenin mutation done by Sanger sequencing was negative in the tumor specimen.</p><p><strong>Conclusion: </strong>AF can occur as a separate tumor in association with PTC. If symptoms are not life-threatening medical management may be a better choice in management.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"15 ","pages":"20363613231172868"},"PeriodicalIF":0.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/38/53/10.1177_20363613231172868.PMC10126633.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9364654","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare case of synchronous follicular thyroid carcinoma arising within a mature cystic ovarian teratoma and stage IV differentiated thyroid cancer in iodine-deficient area in Viet Nam. 越南缺碘地区发生于成熟囊性卵巢畸胎瘤及分化期甲状腺癌的同步滤泡性甲状腺癌1例。
IF 0.9 Q4 ONCOLOGY Pub Date : 2023-01-01 DOI: 10.1177/20363613231161940
Phong Hong Nguyen, Thang Nguyen, Chien Minh Pham

Well-differentiated thyroid carcinoma rarely spreads to soft tissues. Thyroid carcinoma arising within a mature cystic teratoma is even rarer. We report an extremely rare case of synchronous follicular thyroid carcinoma arising within a mature cystic ovarian teratoma and stage IV differentiated thyroid carcinoma. A 62-year-old woman who lived in an iodine-deficient area was accidentally diagnosed with an ovarian cyst during a radiological metastatic work-up for thyroid cancer. Following laparoscopic left salpingo-oophorectomy, histopathological examination revealed a follicular thyroid carcinoma arising within a mature cystic teratoma. After that, total thyroidectomy and surgical resection of the soft tissue lesion in the supraclavicular fossa were performed, and the patient received subsequent 131I ablation therapy, but the disease progression was recorded 3 months later. We believe that iodine deficiency plays a role in the malignant transformation of thyroid tissues within a mature cystic teratoma. In elderly individuals with significant metastases, radioactive iodine therapy is ineffective.

高分化甲状腺癌很少扩散到软组织。甲状腺癌发生在成熟的囊性畸胎瘤是更罕见的。我们报告一例极为罕见的同步滤泡性甲状腺癌发生在成熟的卵巢畸胎瘤和IV期分化甲状腺癌。一位居住在缺碘地区的62岁妇女在甲状腺癌的放射转移检查中被意外诊断为卵巢囊肿。腹腔镜左输卵管卵巢切除术后,组织病理学检查显示成熟囊性畸胎瘤内出现滤泡性甲状腺癌。术后行甲状腺全切除术及锁骨上窝软组织病变手术切除,患者后续接受131I消融治疗,3个月后记录病情进展。我们认为碘缺乏在成熟囊性畸胎瘤中甲状腺组织的恶性转化中起作用。对于有明显转移的老年人,放射性碘治疗无效。
{"title":"A rare case of synchronous follicular thyroid carcinoma arising within a mature cystic ovarian teratoma and stage IV differentiated thyroid cancer in iodine-deficient area in Viet Nam.","authors":"Phong Hong Nguyen,&nbsp;Thang Nguyen,&nbsp;Chien Minh Pham","doi":"10.1177/20363613231161940","DOIUrl":"https://doi.org/10.1177/20363613231161940","url":null,"abstract":"<p><p>Well-differentiated thyroid carcinoma rarely spreads to soft tissues. Thyroid carcinoma arising within a mature cystic teratoma is even rarer. We report an extremely rare case of synchronous follicular thyroid carcinoma arising within a mature cystic ovarian teratoma and stage IV differentiated thyroid carcinoma. A 62-year-old woman who lived in an iodine-deficient area was accidentally diagnosed with an ovarian cyst during a radiological metastatic work-up for thyroid cancer. Following laparoscopic left salpingo-oophorectomy, histopathological examination revealed a follicular thyroid carcinoma arising within a mature cystic teratoma. After that, total thyroidectomy and surgical resection of the soft tissue lesion in the supraclavicular fossa were performed, and the patient received subsequent <sup>131</sup>I ablation therapy, but the disease progression was recorded 3 months later. We believe that iodine deficiency plays a role in the malignant transformation of thyroid tissues within a mature cystic teratoma. In elderly individuals with significant metastases, radioactive iodine therapy is ineffective.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"15 ","pages":"20363613231161940"},"PeriodicalIF":0.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8a/28/10.1177_20363613231161940.PMC9989423.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9085852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lymphangitic carcinomatosis as the initial manifestation of primary signet-ring cell adenocarcinoma of the lung: A case report. 以原发性肺印戒细胞腺癌为首发表现的淋巴管癌1例。
IF 0.9 Q4 ONCOLOGY Pub Date : 2023-01-01 DOI: 10.1177/20363613231164017
David Corredor-Orlandelli, Lina Vargas

Signet-ring cell carcinomas are an aggressive, poorly differentiated, and highly invasive adenocarcinoma carrying a poor prognosis. Most of these tumors originate in gastrointestinal organs; however, primary lung signet-ring cell adenocarcinomas can rarely occur. Tumoral lymphatic infiltration is a complication of these tumors and can cause phenomena such as lymphangitic carcinomatosis, characterized by a nodular thickening of the pleura, pleural effusions, and mediastinal lymphadenopathies. We report a case of a 63-year-old ex-smoker with a 2-week clinical course of dyspnea and pleuritic chest pain in which a nodular thickening of the pleura and pleural effusion were documented and led to the diagnosis of a primary signet-ring cell adenocarcinoma of the lung with lymphangitic carcinomatosis. This complication has never been described in the context of a primary lung tumor of this subtype. Both entities carry a high mortality and have no therapeutical options. This report adds to the information available about them.

印戒细胞癌是一种侵袭性、低分化、高侵袭性的腺癌,预后差。这些肿瘤大多起源于胃肠道器官;然而,原发性肺印戒细胞腺癌很少发生。肿瘤淋巴浸润是这些肿瘤的并发症,可引起淋巴管癌病等现象,其特征是胸膜结节性增厚、胸膜积液和纵隔淋巴结病。我们报告一例63岁的前吸烟者,有2周的临床病程,呼吸困难和胸膜炎性胸痛,胸膜结节增厚和胸膜积液,并导致原发性肺印戒细胞腺癌合并淋巴管癌病的诊断。这种并发症从未在这种亚型的原发性肺肿瘤中被描述过。这两种疾病的死亡率都很高,而且没有治疗选择。这份报告增加了关于他们的可用信息。
{"title":"Lymphangitic carcinomatosis as the initial manifestation of primary signet-ring cell adenocarcinoma of the lung: A case report.","authors":"David Corredor-Orlandelli,&nbsp;Lina Vargas","doi":"10.1177/20363613231164017","DOIUrl":"https://doi.org/10.1177/20363613231164017","url":null,"abstract":"<p><p>Signet-ring cell carcinomas are an aggressive, poorly differentiated, and highly invasive adenocarcinoma carrying a poor prognosis. Most of these tumors originate in gastrointestinal organs; however, primary lung signet-ring cell adenocarcinomas can rarely occur. Tumoral lymphatic infiltration is a complication of these tumors and can cause phenomena such as lymphangitic carcinomatosis, characterized by a nodular thickening of the pleura, pleural effusions, and mediastinal lymphadenopathies. We report a case of a 63-year-old ex-smoker with a 2-week clinical course of dyspnea and pleuritic chest pain in which a nodular thickening of the pleura and pleural effusion were documented and led to the diagnosis of a primary signet-ring cell adenocarcinoma of the lung with lymphangitic carcinomatosis. This complication has never been described in the context of a primary lung tumor of this subtype. Both entities carry a high mortality and have no therapeutical options. This report adds to the information available about them.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"15 ","pages":"20363613231164017"},"PeriodicalIF":0.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8a/08/10.1177_20363613231164017.PMC10014970.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9152994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An incidental discovery of a gastric follicular dendritic cell sarcoma: A rare case report and a literature review. 偶然发现的胃滤泡树突状细胞肉瘤:罕见病例报告及文献复习。
IF 0.9 Q4 ONCOLOGY Pub Date : 2023-01-01 DOI: 10.1177/20363613231172077
Farah Sassi, Ghada Sahraoui, Lamia Charfi, Leila Achouri, Raoudha Doghri, Karima Mrad

Introduction: Follicular dendritic cell sarcomas (FDCS) are rare tumours, typically seen in lymph nodes. However, in about one third of the reported cases, a FDCS presents as an extranodal mass. Involvement of the gastrointestinal tract is rare, and the stomach is even rarer with only four cases described to date. The aim of this study was to review clinical characteristics, pathologic features, emphasize on differential diagnosis and discuss therapeutic modalities and prognosis of this rare entity.Case presentation: We report on a 36-year-old female patient with no past medical history, an incidentally discovered FDCS located in the stomach with the presence of lymph node metastasis at the time of diagnosis. The diagnosis of a FDCS was made on morphological and immunohistochemical findings where tumor cells expressed CD21 and CD23. The tumor was resected by gastrectomy with extended para-aortic lymphadenectomy, with uneventful postoperative course.Conclusions: Due to its rarity, FDCS is rarely included in the differential diagnosis of gastrointestinal spindle cell tumors. Complete surgical resection is the current gold standard of treatment.

简介:滤泡树突状细胞肉瘤(FDCS)是一种罕见的肿瘤,多见于淋巴结。然而,在大约三分之一的报告病例中,FDCS表现为结外肿块。累及胃肠道的病例很少见,而累及胃的病例则更为罕见,迄今为止仅有4例。本研究的目的是回顾临床特点,病理特征,强调鉴别诊断,并讨论治疗方式和预后这种罕见的实体。病例介绍:我们报告一位36岁女性患者,无既往病史,在诊断时偶然发现位于胃的FDCS并伴有淋巴结转移。FDCS的诊断是通过肿瘤细胞表达CD21和CD23的形态学和免疫组织化学结果进行的。经胃切除术合并腹主动脉旁淋巴结切除术,手术过程顺利。结论:由于FDCS的罕见性,它很少被纳入胃肠道梭形细胞瘤的鉴别诊断。完全手术切除是目前治疗的金标准。
{"title":"An incidental discovery of a gastric follicular dendritic cell sarcoma: A rare case report and a literature review.","authors":"Farah Sassi,&nbsp;Ghada Sahraoui,&nbsp;Lamia Charfi,&nbsp;Leila Achouri,&nbsp;Raoudha Doghri,&nbsp;Karima Mrad","doi":"10.1177/20363613231172077","DOIUrl":"https://doi.org/10.1177/20363613231172077","url":null,"abstract":"<p><p><b>Introduction:</b> Follicular dendritic cell sarcomas (FDCS) are rare tumours, typically seen in lymph nodes. However, in about one third of the reported cases, a FDCS presents as an extranodal mass. Involvement of the gastrointestinal tract is rare, and the stomach is even rarer with only four cases described to date. The aim of this study was to review clinical characteristics, pathologic features, emphasize on differential diagnosis and discuss therapeutic modalities and prognosis of this rare entity.<b>Case presentation:</b> We report on a 36-year-old female patient with no past medical history, an incidentally discovered FDCS located in the stomach with the presence of lymph node metastasis at the time of diagnosis. The diagnosis of a FDCS was made on morphological and immunohistochemical findings where tumor cells expressed CD21 and CD23. The tumor was resected by gastrectomy with extended para-aortic lymphadenectomy, with uneventful postoperative course.<b>Conclusions:</b> Due to its rarity, FDCS is rarely included in the differential diagnosis of gastrointestinal spindle cell tumors. Complete surgical resection is the current gold standard of treatment.</p>","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"15 ","pages":"20363613231172077"},"PeriodicalIF":0.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bf/d0/10.1177_20363613231172077.PMC10134144.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9450501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Rare Tumors
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1